Retraction Note: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor
- DOI
- 10.1186/s12885-026-16727-3
- Published
- 2026-08-14
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-16727-3,
title = {Retraction Note: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor},
author = {Chia-Chi Liu and Ching-Fang Yu and Shu-Chi Wang and Hsueh-Yin Li and Chiu-Min Lin and Hsia-Han Wang and Carmen Abate and Chi-Shiun Chiang},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-026-16727-3},
url = {https://doi.org/10.1186/s12885-026-16727-3}
}RIS
TY - JOUR TI - Retraction Note: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor AU - Chia-Chi Liu AU - Ching-Fang Yu AU - Shu-Chi Wang AU - Hsueh-Yin Li AU - Chiu-Min Lin AU - Hsia-Han Wang AU - Carmen Abate AU - Chi-Shiun Chiang PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-026-16727-3 UR - https://doi.org/10.1186/s12885-026-16727-3 ER -
APA
Liu, C., Yu, C., Wang, S., Li, H., Lin, C., Wang, H., Abate, C., & Chiang, C. (2026). Retraction Note: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor. BMC Cancer. https://doi.org/10.1186/s12885-026-16727-3
Source records
- crossref · retrieved 2026-09-26T00:20:57.929Z